Apollo Hospitals Enterprise Limited has informed the Exchange about Action(s) taken or orders passed
APOLLOHOSP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts less than Nifty 100 and 0.9 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Apollo Hospitals' subsidiary Apollo Healthco Limited (AHL) had filed a compounding application with the Reserve Bank of India for a contravention of Rule 4 read with Rule 2(k) of the Foreign Exchange Management (Non-debt Instruments) Rules, 2019. The RBI, via an order dated July 31, 2025, has directed AHL to deposit ₹4,95,50,000 (approximately ₹4.96 crores) to compound the contravention. The company states there are no further claims, penalties, or proceedings pending in relation to this matter. Apollo Hospitals confirms there is no material impact on its financial position, operations, or future outlook due to this order.
The ₹4.96 crore penalty on the subsidiary is minor relative to Apollo Hospitals' overall scale and the company explicitly states no financial or operational impact. Shareholders are unlikely to see a meaningful effect on the stock price, though it highlights regulatory scrutiny on the digital/pharmacy subsidiary.